-
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 20232024-03-26
-
FINAL DIVIDEND FOR THE YEAR ENDED DECEMBER 31, 20232024-03-26
-
VOLUNTARY ANNOUNCEMENT - LICENSING AGREEMENT WITH BIOTHEUS2024-03-14
-
DATE OF BOARD MEETING2024-03-14
-
Letter to Register Shareholders - NEW ARRANGEMENTS ON DISSEMINATION OF CORPORATE COMMUNICATIONS2024-03-11
-
Letter to Non-Register Shareholders - NEW ARRANGEMENTS ON DISSEMINATION OF CORPORATE COMMUNICATIONS2024-03-11
-
NEW ARRANGEMENTS ON DISSEMINATION OF CORPORATE COMMUNICATIONS2024-03-11
-
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 20242024-03-01
-
VOLUNTARY ANNOUNCEMENT - CLINICAL TRIAL NOTICE OF "HS-10398 CAPSULES"2024-02-07
-
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 20242024-02-01
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO THE RESTRICTED SHARE UNIT SCHEME2024-01-31
-
VOLUNTARY ANNOUNCEMENT - CLINICAL TRIAL NOTICE OF "HS-10501 TABLETS"2024-01-22
